Diagnosis and classification of von Willebrand disease
- 1 October 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 22 (7) , 553-564
Abstract
Von Willebrand disease (VWD) is considered to be the most common inherited bleeding disorder. VWD is diagnosed following a clinical and physical review, with personal and familial evidence of (primarily mucocutaneous) bleeding, and confirmed by laboratory testing. The latter typically entails initial plasma testing of factor VIII coagulant, von Willebrand factor (VWF) protein ('antigen') and VWF function which has classically been assessed using the ristocetin cofactor (VWF:RCo) assay. More recent attention has focussed on other functional VWF assays, such as collagen binding and so-called 'VWF activity' assays, as possible replacements to the VWF:RCo, or as supplementary tests of VWF 'function'. Additional laboratory testing can comprise a battery of confirmatory and VWD-type assisting assays, including VWF:multimer and von Willebrand factor VIII binding. This review aims to update knowledge of current VWD diagnostics with a particular emphasis on 'functional' VWF assays.Keywords
This publication has 67 references indexed in Scilit:
- Diagnosis and Management ofvon Willebrand Disease in AustraliaSeminars in Thrombosis and Hemostasis, 2011
- Diagnosis and Management of Adult Patients withvon Willebrand Disease in South AustraliaSeminars in Thrombosis and Hemostasis, 2011
- von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding DisorderSeminars in Thrombosis and Hemostasis, 2011
- Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assayJournal of Thrombosis and Haemostasis, 2010
- Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWDJournal of Thrombosis and Haemostasis, 2010
- Genetic testing for von Willebrand disease: the case againstJournal of Thrombosis and Haemostasis, 2010
- Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand diseaseBlood Coagulation & Fibrinolysis, 2009
- Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implicationsThrombosis Journal, 2007
- External Peer Review Quality Assurance Testing in von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing ProgramSeminars in Thrombosis and Hemostasis, 2006
- Reassessment of ABO Blood Group, Sex, and Age on Laboratory Parameters Used to Diagnose von Willebrand DisorderAmerican Journal of Clinical Pathology, 2005